Results 131 to 140 of about 66,189,794 (208)

Gilles de la Tourette Syndrome: advice in the times of COVID-19. [PDF]

F1000Res, 2020
Robertson MM, Eapen V, Rizzo R, Stern JS, Hartmann A.   +4 more
europepmc   +1 more source

Pathological glutamatergic neurotransmission in Gilles de la Tourette Syndrome

We hypothesized that glutamatergic signalling is related to pathophysiology of Gilles de la Tourette syndrome (GTS) and investigated glutamatergic metabolism within cortico-striatal regions using 1H-MRS at baseline and during treatment.
Pampel, A. ; https://orcid.org/, Near, J., Gerasch, S., Müller-Vahl, K., García-García, I., Anwander, A., Möller, H. ; https://orcid.org/, Kanaan, A., Lampe, L.   +8 more
core  

Deep Brain Stimulation for Gilles de la Tourette Syndrome: Toward Limbic Targets. [PDF]

Brain Sci, 2020
Servello D, Galbiati TF, Balestrino R, Iess G, Zekaj E, Michele S, Porta M.   +6 more
europepmc   +1 more source

Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions. [PDF]

Front Neurol, 2020
Bjerregaard VA, Schönewolf-Greulich B, Juel Rasmussen L, Desler C, Tümer Z.   +4 more
europepmc   +1 more source

Mapping Gilles de la Tourette syndrome through the distress and relief associated with tic-related behaviors: an fMRI study. [PDF]

Transl Psychiatry
Zapparoli L, Devoto F, Mariano M, Seghezzi S, Servello D, Porta M, Paulesu E.   +6 more
europepmc   +1 more source

Altered sense of agency in Gilles de la Tourette syndrome: behavioural, clinical and functional magnetic resonance imaging findings. [PDF]

Brain Commun, 2020
Zapparoli L, Seghezzi S, Devoto F, Mariano M, Banfi G, Porta M, Paulesu E.   +6 more
europepmc   +1 more source

Genome-Wide Association Study Points to Novel Locus for Gilles de la Tourette Syndrome. [PDF]

Biol Psychiatry
Tsetsos F, Topaloudi A, Jain P, Yang Z, Yu D, Kolovos P, Tumer Z, Rizzo R, Hartmann A, Depienne C, Worbe Y, Müller-Vahl KR, Cath DC, Boomsma DI, Wolanczyk T, Zekanowski C, Barta C, Nemoda Z, Tarnok Z, Padmanabhuni SS, Buxbaum JD, Grice D, Glennon J, Stefansson H, Hengerer B, Yannaki E, Stamatoyannopoulos JA, Benaroya-Milshtein N, Cardona F, Hedderly T, Heyman I, Huyser C, Mir P, Morer A, Mueller N, Munchau A, Plessen KJ, Porcelli C, Roessner V, Walitza S, Schrag A, Martino D, PGC TS Working Group, TSAICG, TSGeneSEE Initiative, EMTICS Collaborative Group, TS-EUROTRAIN Network, TIC Genetics Collaborative Group, Tischfield JA, Heiman GA, Willsey AJ, Dietrich A, Davis LK, Crowley JJ, Mathews CA, Scharf JM, Georgitsi M, Hoekstra PJ, Paschou P.   +58 more
europepmc   +1 more source

Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome. [PDF]

Front Genet, 2020
Szejko N, Fichna JP, Safranow K, Dziuba T, Żekanowski C, Janik P.   +5 more
europepmc   +1 more source

Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL). [PDF]

PLoS One, 2020
Jalenques I, Cyrille D, Derost P, Hartmann A, Lauron S, Jameux C, Tauveron-Jalenques U, Guiguet-Auclair C, Rondepierre F, Syndrome de Gilles de La Tourette Study Group.   +9 more
europepmc   +1 more source

Relationship between transcranial magnetic stimulation markers of motor control and clinical recovery in obsessive compulsive disorder/Gilles de la Tourette syndrome: a proof of concept case study. [PDF]

Front Psychiatry
Quoilin C, Chaise F, Duque J, de Timary P.   +3 more
europepmc   +1 more source